Home » Stocks » Cerecor

Cerecor Inc. (CERC)

Stock Price: $2.59 USD 0.07 (2.58%)
Updated Aug 14, 2020 11:06 AM EDT - Market open

Stock Price Chart

Key Info

Market Cap 193.62M
Revenue (ttm) 6.87M
Net Income (ttm) -36.79M
Shares Out 74.90M
EPS (ttm) -0.73
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 14, 2020
Last Price $2.59
Previous Close $2.52
Change ($) 0.07
Change (%) 2.58%
Day's Open 2.51
Day's Range 2.50 - 2.60
Day's Volume 157,162
52-Week Range 1.52 - 6.19

More Stats

Market Cap 193.62M
Enterprise Value 148.19M
Earnings Date (est) Nov 10, 2020
Ex-Dividend Date n/a
Shares Outstanding 74.90M
Float 36.05M
EPS (basic) -0.57
EPS (diluted) -0.73
FCF / Share -0.40
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.47M
Short Ratio 1.72
Short % of Float 2.61%
Beta 1.81
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 28.17
PB Ratio 4.17
Revenue 6.87M
Operating Income -46.81M
Net Income -36.79M
Free Cash Flow -23.59M
Net Cash 45.42M
Net Cash / Share 0.61
Gross Margin -70.98%
Operating Margin -681.01%
Profit Margin -3,750.10%
FCF Margin -343.26%
ROA -25.19%
ROE -127.56%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$10.00*
Low
10.0
Current: $2.59
High
10.0
Target: 10.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013
Revenue6.757.0327.811.15---
Revenue Growth-3.96%-74.73%2312.27%----
Gross Profit7.323.7727.181.15---
Operating Income-17.39-35.4913.89-16.08-11.01-17.12-12.93
Net Income-16.07-40.057.77-16.47-10.49-3.52-13.13
Shares Outstanding44.1134.7718.418.832.230.640.63
Earnings Per Share-0.28-1.200.42-1.87-4.71-5.48-20.72
Operating Cash Flow-19.13-3.1312.58-14.57-10.16-15.52-11.49
Capital Expenditures-0.26-0.56-0.02-0.03-0.02-0.02-0.03
Free Cash Flow-19.40-3.6912.56-14.61-10.18-15.54-11.51
Cash & Equivalents11.2610.672.475.1421.2211.803.42
Total Debt---2.355.567.21-
Net Cash / Debt11.2610.672.472.7915.664.593.42
Assets36.1170.2542.815.7721.6612.325.08
Liabilities15.1149.3414.955.568.5710.303.07
Book Value21.0020.9127.860.2113.08-26.33-17.85
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Cerecor Inc.
Country United States
Employees 18
CEO Michael F. Cola

Stock Information

Ticker Symbol CERC
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: CERC
IPO Date October 15, 2015

Description

Cerecor Inc., a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Ulesfia, Karbinal ER, AcipHex Sprinkle, and Cefaclor for oral suspension, as well as Flexichamber a medical device. The company is developing CERC-301, an orphan neurological indication for controlling neurologic adaptation; CERC-406 for the treatment of Parkinson's disease; CERC-425, an orally active small molecule; CERC-611, a drug candidate for the treatment of partial-onset seizures in epilepsy; and CERC-913, a protide nucleotide for the treatment of mitochondrial disorder. It also developing preclinical therapies CERC-801, CERC-802, and CERC-803 for the treatment of inherited metabolic disorders. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor Inc. was founded in 2011 and is headquartered in Rockville, Maryland.